SCHEMBL3047079

SCHEMBL3047079

COc1ccc(/C(=C\c2ccc(OC)c(OC)c2)C(=O)O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.72
KDM4E B2RXH2 2/20 0.67
HTT P42858 1/20 0.67
NQO2 P16083 1/20 0.65
TNFRSF1A P19438 2/20 0.60
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
ALDH1A1 P00352 3/20 0.58
ABCG2 Q9UNQ0 3/20 0.57
POLB P06746 1/20 0.56
AKR1C2 P52895 1/20 0.56
GAA P10253 2/20 0.55
PDE4A P27815 2/20 0.54
PDE4B Q07343 2/20 0.54
PDE4C Q08493 2/20 0.54
PDE4D Q08499 2/20 0.54
TUBB4A P04350 1/20 0.54
TUBB P07437 1/20 0.54
TUBA3C P0DPH7 1/20 0.54
TUBA1B P68363 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3047082 1.00 AKR1C3 (0.72) AKR1C3KDM4EHTTNQO2TNFRSF1A
SCHEMBL12507695 0.91 AKR1C3 (0.68) AKR1C3KDM4EHTTNQO2TNFRSF1A
SCHEMBL5314275 0.90 KDM4E (0.80) AKR1C3KDM4EHTTNQO2TNFRSF1A
SCHEMBL5314277 0.90 KDM4E (0.80) AKR1C3KDM4EHTTNQO2TNFRSF1A
SCHEMBL31510188 0.89 AKR1C3 (0.66) AKR1C3KDM4EHTTNQO2TNFRSF1A
SCHEMBL14125351 0.89 CXCL12 (0.62) AKR1C3KDM4EHTTNQO2MEN1
SCHEMBL14125352 0.89 CXCL12 (0.62) AKR1C3KDM4EHTTNQO2MEN1
SCHEMBL4659113 0.89 AKR1C3 (0.68) AKR1C3KDM4EHTTNQO2MEN1
SCHEMBL4659114 0.89 AKR1C3 (0.68) AKR1C3KDM4EHTTNQO2MEN1
SCHEMBL30159708 0.89 AKR1C3 (0.68) AKR1C3KDM4EHTTNQO2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476255-B2 Histone deacetylase inhibitors ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2013-07-02 US disclosed
US-20100222379-A1 NOVEL HISTONE DEACETYLASE INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2010-09-02 US disclosed
EP-2205563-A2 NOVEL HISTONE DEACETYLASE INHIBITORS Orchid Research Laboratories Limited (IN) 2010-07-14 EP disclosed
WO-2009047615-A2 NOVEL HISTONE DEACETYLASE INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222379-A1 NOVEL HISTONE DEACETYLASE INHIBITORS HDAC5, HDAC2, HDAC1 AKR1C3 520/4885KDM4E 801/4885HTT 2279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.